Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Similar documents
1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany

Validation of the OMRON 705 IT blood pressure measuring device according to the International Protocol of the European Society of Hypertension

Validation Study Result Form

and bias, which are known to be present in self-home and in professional office BP measurements taken using the auscultatory technique [7].

Validation Study Result Form

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

DR JIRAR TOPOUCHIAN PROF PAROUNAK ZELVEIAN PROF ROLAND ASMAR. September 8 th, Principal Investigator and Study Chair:

Maker Spacelabs Healthcare Manufacturer Spacelabs Healthcare. Brand Spacelabs Model OnTrak

Validation study of the Dinamap ProCare 200 upper arm blood pressure monitor in children and adolescents

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)

Methods DEVICES AND TECHNOLOGY

a Medical Physics Department, Guy s & St Thomas NHS Foundation Trust and b King s College School of Medicine, St Thomas Campus, London, UK

Received 10 April 2008 Revised 23 June 2008 Accepted 24 June 2008

a Centre de Médecine Cardiovasculaire, Paris, France, b Lebanese Hospital and Received 7 June 2009 Revised 15 September 2009 Accepted 9 October 2009

Unreliable oscillometric blood pressure measurement: prevalence, repeatability and characteristics of the phenomenon

DEVICES AND TECHNOLOGY

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and

Comparison of manual versus automated blood pressure measurement in intensive care unit, coronary care unit, and emergency room.

Céline Guggiari a, Christophe Büla a, Katia Iglesias b and Bernard Waeber b,c

Comparison of the Microlife A2 Basic (BP3GQ1-3P) with the Microlife BP3BT0-A and Microlife BP A100 Plus

Received 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015

Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients?

Home blood pressure measurement with oscillometric upper-arm devices

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Does Talking and Different Body (Sitting, Supine, Standing) Positions affect Blood Pressure?

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods

HOW CONSISTENT ARE THE BLOOD PRESSURE AND PULSE RATE MEASUREMENTS OF THE ELECTRONIC BP APPARATUS AND THE MANUAL SPHYGMOMANOMETER

Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Device Judgement Recommended

Special articles from the ESH working group on blood pressure monitoring 23

Comparison of two oscillometric blood pressure monitors in subjects with atrial fibrillation

In clinical practice, blood pressure (BP) treatment

Comparison of the Microlife A6 PC (BP3GU1-8Y) with the Microlife BP3BT0-A and Microlife BP A100 Plus

Data Collection Worksheet

AFFORDABLE TECHNOLOGY

Evaluation of the Accutracker I1 noninvasive ambulatory blood pressure recorder according to the AAMI Standard

Validity study of oscillometric blood pressure measurement devices using an oscillometric waveform simulator

Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation

THE ACCURATE ASSESSMENT

Copyright: DOI link to paper: Date deposited: This work is licensed under a Creative Commons Attribution 2.5 Generic License

STATE OF THE ART BP ASSESSMENT

Auscultatory versus oscillometric blood pressure measurement in patients with atrial fibrillation and arterial hypertension

Validation of the Noninvasive Assessment of Central Blood Pressure by the SphygmoCor and Omron Devices Against the Invasive Catheter Measurement

The Value of a BP Determination Method Using a Novel Non-Invasive BP Device against the Invasive Catheter Measurement

The increasing awareness of hypertension as a serious

IDENTIFYING MASKED UNCONTROLLED HYPERTENSION IN THE. RUNNING HEAD: Factors associated with masked uncontrolled hypertension.

Declaration of Equivalence Form

Taking and recording blood pressure and pulse. City Gate Training Centre all rights reserved

BRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.

doi: /fampra/cmw053

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

The introduction of oscillometric automated blood pressure

LEARNING OUTCOME The students will be able to elicit vital signs correctly on human volunteers/patients

MANUAL BLOOD PRESSURE MONITOR BPM 168B Contents Blood Pressure Monitor Intended Use What is blood pressure?

Clinical Evaluation of an Oscillometric NIBP Technology During Hemodialysis According to the British Hypertension Society Protocol

Device Equivalence Evaluation Form

1 Department of Medical Physics, Royal Infirmary of Edinburgh, 2 Department of. Received 11 June 2004 Accepted 7 September 2004

A GUIDE TO OUR NIBP TECHNOLOGY

When the BHS dissolved its Working Party on Blood Pressure Measurement, the Working Group on Blood

Validation Study Registration Form

Biomedical Instrumentation E. Blood Pressure

SECTION 16: BLOOD PRESSURE MEASUREMENT

Ambulatory blood pressure monitoring (ABPM) is. Accuracy of Ambulatory Blood Pressure Monitors in Routine Clinical Practice.

Owner's Manual. Arm-type Fully Automatic Digital Blood Pressure Monitor. Arm Type. Model BSP-11

Research Article Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study

European Society of Hypertension Practice Guidelines for home blood pressure monitoring

greater than 90% of patients having blood pressure measured consistently according to the protocol.

Slide notes: References:

White coat and masked hypertension

BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?

RESEARCH INTRODUCTION

Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents

Use and Interpretation of Home Blood Pressure Monitoring

Impact of Miscuffing During Home Blood Pressure Measurement on the Prevalence of Masked Hypertension

No. 1 cause of invalidity No. 2 cause of dementia No. 3 cause of death

2. Measure a subject's blood pressure and heart rate both at rest and during exercise.

Importance Of Taking Manual Blood Pressure In Both Arms

The measurement of blood pressure and hypertension. Handout Fenyvesi Tamás III.Department of Medicine

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE. MEASURING BLOOD PRESSURE - MANUAL (equ04)

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

There is convincing evidence in clinical studies

LAB 9: Metabolic Rates

Comparison of Three Measures of the Ankle-Brachial Blood Pressure Index in a General Population

Chapter 29 1/8/2018. Vital Signs. Measuring and Reporting Vital Signs. Key Terms

The EARNEST study : interarm blood pressure differences should also be recorded Moody, William; Ferro, Charles; Townend, Jonathan

AP Biology Lab 10 PHYSIOLOGY OF THE CIRCULATORY SYSTEM

When should blood pressure be lowered? Should treatment be guided by blood pressure values or total cardiovascular risk?

Device Equivalence Evaluation Form

Continuous Monitoring of Blood Pressure Based on Heart Pulse Analysis

Chapter 15: Measuring Height, Weight, and Vital Signs. Copyright 2012 Wolters Kluwer Health Lippincott Williams & Wilkins

Device Equivalence Evaluation Form

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL

Association Between Non-Dipping and Fragmented QRS Complexes in Prehypertensive Patients

PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN

Lecture #3 - Blood Pressure Recording Procedure. Equipment

BLOOD PRESSURE ASSESSMENT

Special Lecture 10/28/2012

Transcription:

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation of the SEJOY BP-1307 blood pressure monitor Lei Lei, Yi Chen, Qi Chen, Yan Li, Ji-Guang Wang Word counts: Manuscript 1933, Abstract 222; Number: Tables 5; Figure 1 Correspondence: Ji-Guang Wang, MD, PHD, The Shanghai Institute of Hypertension, Ruijin 2nd Road 197, Shanghai 200025, China. Phone: +86-21-64370045 ext. 610911 Fax: +86-21-64662193 E-mail: jiguangwang@aim.com

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 2 Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Correspondence to Ji-Guang Wang, MD, PhD, The Shanghai Institute of Hypertension, Ruijin 2nd Road 197, Shanghai 200025, China Tel: +86 21 6437 0045 ext 610911; fax: +86 21 6466 2193; email: jiguangwang@aim.com

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 3 Abstract Objective The present study aimed to evaluate the accuracy of the automated oscillometric upper arm blood pressure monitor SEJOY BP-1307 (also called JOYTECH DBP-1307) for home blood pressure monitoring according to the International Protocol of the European Society of Hypertension revision 2010. Method Systolic and diastolic blood pressures were sequentially measured in 33 adult Chinese (13 women, 45.1 years of mean age) using a mercury sphygmomanometer (two observers) and the SEJOY BP-1307 device (one supervisor). Ninety-nine pairs of comparisons were obtained from 33 participants for judgments in two parts with three grading phases. Results The SEJOY BP-1307 device achieved the targets in part 1 of the validation study. The number of absolute differences between device and observers within 5, 10 and 15 mmhg was 84/99, 96/99, and 98/99, respectively, for systolic blood pressure, and 74/99, 96/99, and 98/99, respectively, for diastolic blood pressure. The device also achieved the criteria in part 2 of the validation study. Twenty-nine and 27 participants for systolic and diastolic blood pressure, respectively, had at least two of the three device-observers differences within 5 mmhg (required 24). Only one participant for diastolic blood pressure had all the three device-observers comparisons greater than 5 mmhg. Conclusions The SEJOY upper arm blood pressure monitor BP-1307 has passed the requirements of the International Protocol revision 2010, and hence can be recommended for home use in adults.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 4 Key words: SEJOY BP-1307, blood pressure measurement, blood pressure monitor, validation study, European Society of Hypertension International Protocol

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 5 Introduction Current guidelines recommend the use of upper arm blood pressure monitors for home blood pressure monitoring and indicate that only validated blood pressure monitors should be used [1, 2]. SEJOY is a manufacturer of automated oscillometric blood pressure monitors under its own brand name and as an original equipment manufacturer. In the present study, we assessed the accuracy of the upper-arm blood pressure monitor SEJOY BP-1307 for blood pressure measurement in adult Chinese according to the revision 2010 of the European Society of Hypertension International Protocol (ESH-IP2010) for validation of BP measuring devices in adults [3]. Methods Familiarisation Twelve test measurements were carried out and no problems were encountered. Participants Study participants were men and women between 26 and 84 years of age, and were randomly recruited from the staff and hypertensive patients in Ruijin Hospital (Shanghai, China). We excluded individuals with cardiac arrhythmias and peripheral arterial disease. For practical reasons, we also excluded patients with known heart disease or diagnosed secondary hypertension. The Ethics Committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine, approved the study protocol. All participants gave informed written consent. We administered a short questionnaire to collect information on medical history, and measured body height, body weight and arm circumference.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 6 The selected participants were categorized fitting three systolic blood pressure ranges ( 129, 130 160, and 161 mmhg) and three diastolic blood pressure ranges ( 79, 80 100, and 101 mmhg) required by the International Protocol rules [3]. The SEJOY BP-1307 device The SEJOY BP-1307 device is an automated electronic digital upper arm blood pressure monitor. The device operates through oscillometric technique, and is designed mainly for self-blood pressure measurement at home. The device requires four 1.5 V AA alkaline batteries as energy source or uses the adapter to input external power (6.0 volts, 600 ma). The device has a semi-conductive pressure sensor designed to measure blood pressure values ranging from 0 to 300 mmhg and pulse rate values from 30 to 180 beats per minute. The declared specific accuracy is ±3 mmhg for blood pressure and ±5% for pulse rate. The device has two memory zones and a memory capacity of 60 readings each. The cuff is suitable for upper arm circumferences from 22.0 to 42.0 cm. During measurement, the bottom edge of the cuff should be positioned approximately one inch above the elbow joint, meanwhile the forearm and the device should be on a table with the palm facing up and the device at the heart level. The manufacturer provided three blood pressure monitors, one of which was randomly selected for the validation process. Validation procedure The validation procedure strictly followed the International Protocol revision 2010, and

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 7 was carried out by a team of three investigators experienced in blood pressure measurement and trained repeatedly by the use of an educational video program for blood pressure measurement produced by the British Society of Hypertension (Registered Charity Number 287635). Blood pressure was measured in the sitting position with the forearm at the level of the heart according to the European recommendations [4]. For each subject, blood pressure was sequentially measured using a mercury sphygmomanometer (two observers) and the SEJOY BP-1307 device (one supervisor). During the whole process, the two observers used a Y-tubing dual head stethoscope to obtain the blood pressure readings separately and did not know each other s readings and the device readings. A pause of 30 60 seconds was allowed between two successive measurements. In addition, the digital signals of the pressure and the oscillations were recorded during the device measurement for the real-time monitoring of pulse rhythm. Data analysis For each of the three systolic and three diastolic blood pressure readings recorded by the device, two absolute differences were calculated by subtracting, respectively, the mean of the preceding and the following measurements taken by the two observers with the mercury sphygmomanometer. The smaller one of the two absolute differences was used and categorized into one of the three bands ( 5, 10 and 15 mm Hg) according to its rounded value [3]. These differences were presented in numbers in tabular format and against the mean of the device and observers measurements in scatter plots.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 8 Results Demographic and clinical data Of the 42 consecutively screened participants, 9 were excluded for reasons detailed in Table 1, leaving 33 participants enrolled in the study. All 33 subjects had systolic and diastolic blood pressure in the required ranges. The study was conducted on the left upper arm in all subjects. During the study, there was no measurement failure for the device. The 33 study participants (20 men and 13 women) had a mean (±SD) age of 45.1±15.5 years (range, 26.0 to 84.0 years) and a mean body mass index of 24.5 ± 3.6 kg/m². The arm circumference was 28.0 ± 2.1 cm (range, 22.0 to 32.0 cm). Mean systolic/diastolic blood pressures at recruitment were 145.8 ± 25.1/88.6 ± 20.9 mmhg (Table 2). Validation of the SEJOY BP-1307 device The SEJOY BP-1307 device achieved the targets in part 1 of the validation study. The number of observer test measurements in each pressure range was between 27 and 39, and hence the difference between the range with the highest count and that with the lowest count was 12. The overall systolic blood pressure range was from 88 to 184 mmhg and the overall diastolic blood pressure range from 49 to 124 mmhg (Table 3). There was only one subject with systolic blood pressure outside the range from 90-180 mmhg and none with diastolic blood pressure outside the range from 40-130 mmhg.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 9 The observer differences for systolic and diastolic blood pressure were within -4 to 4 mmhg, with a mean (±standard deviation) value of -0.5 ± 1.7 mmhg and -0.5 ± 1.7 mmhg, respectively. For all the included subjects, twelve repeated measurements were obtained (Table 4). The number of absolute differences between device and observers within 5, 10, and 15 mmhg was 84/99, 96/99, and 98/99, respectively, for systolic blood pressure, and 74/99, 96/99, and 98/99, respectively, for diastolic blood pressure (Table 5 and Figure 1). Twenty-nine participants for systolic blood pressure and 27 for diastolic blood pressure had at least two of the three device-observers differences within 5 mmhg (required 24). One participant for diastolic blood pressure had all the three device-observers comparisons greater than 5 mmhg (Table 5). Device-observers mean differences The average (±SD) of the device-observers differences was 0.2 ± 4.1 mmhg and -1.7 ± 4.7 mmhg for systolic and diastolic blood pressure, respectively (Table 5). Figure 1 presents the scatter plots of device-observers differences against the average of device and observers values for the 99 pairs of comparisons. Discussion The results of the present study demonstrated that the SEJOY upper arm blood pressure monitor BP-1307 passed the validation for both systolic and diastolic blood pressures according to the International Protocol revision 2010 [3]. In our study, the graphical presentations of the device-observers differences in systolic

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 10 and diastolic blood pressures showed a fair agreement between the mercury sphygmomanometer and the SEJOY BP-1307 device. Only one dot each for systolic and diastolic blood pressure was outside the ±15 mmhg limits and only one subject had all the three device-observers differences greater than 5 mm Hg for diastolic blood pressure. The SEJOY BP-1307 device has a so-called whole range cuff, which is suitable for arm circumferences from 22 cm to 42 cm. It would be possible for overweight and obese subjects to measure their blood pressures with the same cuff. Conclusion The SEJOY upper arm blood pressure monitor BP-1307 has passed the International Protocol revision 2010 requirements, and hence can be recommended for blood pressure measurement at home in adults.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 11 Acknowledgement Sejoy Electronic & Instruments Co., Ltd (Hangzhou, Zhejiang Province, China) provided funding for this validation study. The authors gratefully acknowledge the expert technical assistance of Yi Zhou (The Shanghai Institute of Hypertension, Shanghai, China). Conflicts of interest Dr Wang reports receiving lecture and consulting fees from A&D, Novartis, Omron, Pfizer, Sankyo, Servier, and Takeda. For the remaining authors,there are no conflicts of interest.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 12 References 1 Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357. 2 Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 2010; 24:779-785. 3 O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15:23-38. 4 O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 13 Figure legend Fig. 1 Scatter plots of the (a) systolic and (b) diastolic blood pressure differences between the SEJOY BP-1307 device and observers (y-axis) against the average of device and observers pressure values (x-axis).

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 14 Table 1. Screening and recruitment details Screening and recruitment Recruitment ranges Total screened 42 mmhg Number of subjects Total excluded 9 <90 0 Low Ranges complete 0 90 129 10 Number of subjects on antihypertensive drugs 5 Range adjustment 6 SBP Medium 130 160 12 11 Arrhythmias 1 161 180 10 High Device failure 0 >180 1 Poor quality sounds 1 10 Peripheral arterial disease 1 Cuff size unavailable 0 <40 0 Low Observer disagreement 0 40 79 11 8 Distribution 0 DBP Medium 80 100 10 8 Other reasons 0 101 130 12 High Total recruited 33 >130 0 10 SBP, systolic blood pressure; DBP, diastolic blood pressure.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 15 Table 2. Participants details Sex Male : female 20 : 13 Age (years) Range (low : high) 26 : 84 Mean (SD) 45.1 (15.5) Arm circumference (cm) Range (low : high) 22 : 32 Mean (SD) 28.0 (2.1) Cuff for tested device 22-42 cm (arm) 33 BP range (mmhg) (low : high) SBP 98 : 182 DBP 46 : 124 Mean (SD) SBP 145.8 (25.1) SBP, systolic blood pressure; DBP, diastolic blood pressure. DBP 88.6 (20.9)

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 16 Table 3. Observer measurements in each recruitment range SBP (mmhg) DBP (mmhg) Overall range (low : high) 88 : 184 Overall range (low : high) 49 : 124 Low (< 130) 29 Low (< 80) 39 Medium (130-160) 37 Medium (80-100) 33 High (>160) 33 High (>100) 27 Maximum difference 8 Maximum difference 12 SBP, systolic blood pressure; DBP, diastolic blood pressure.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 17 Table 4. Differences in observers measurements Repeated Observer 2 observer 1 SBP (mmhg) DBP (mmhg) measurements Range (low : high) 4 : +4 4 : +4 12 Mean (SD) 0.5 (1.7) 0.5 (1.7) SBP, systolic blood pressure; DBP, diastolic blood pressure.

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 18 Table 5. Accuracy of the SEJOY BP1307 device according to the International Protocol revision 2010 for the validation of blood pressure measuring devices in adults 5 mmhg 10mmHg 15mmHg Grade 1 Mean difference (mmhg) Standard deviation (mmhg) Part 1 Required Two of 73 87 96 All of 65 81 93 Achieved SBP 84 96 98 Pass 0.2 4.1 DBP 74 96 98 Pass -1.7 4.7 Part 2 2/3 5mmHg 0/3 5 mmhg Grade 2 Grade 3 Required 24 3 Achieved SBP 29 0 Pass Pass DBP 27 1 Pass Pass Part 3 SBP, systolic blood pressure; DBP, diastolic blood pressure. Result Pass

Lei et al. Validation of the SEJOY BP-1307 blood pressure monitor 19 Figure 1 (a) (b)